{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:49:38Z","timestamp":1794005378237,"version":"4.8.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejmech.2021.113946","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T17:55:01Z","timestamp":1634925301000},"page":"113946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"special_numbering":"C","title":["Medicinal chemistry updates of novel HDACs inhibitors (2020 to present)"],"prefix":"10.1016","volume":"227","author":[{"given":"Xingrui","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renren","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0723-4083","authenticated-orcid":false,"given":"Zongcheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3739-0930","authenticated-orcid":false,"given":"Xiang-Yang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113946_bib1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41573-019-0030-7","article-title":"Bromodomains: a new target class for drug development","volume":"18","author":"Cochran","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113946_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.gene.2015.02.045","article-title":"The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: a review","volume":"562","author":"Vahid","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.ejmech.2021.113946_bib3","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/bib\/bbt060","article-title":"Systematic identification of Class I HDAC substrates","volume":"15","author":"Li","year":"2014","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.ejmech.2021.113946_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/13543776.2020.1725470","article-title":"Histone deacetylase (HDAC) inhibitors in cancer: a patent review (2017-present)","volume":"30","author":"Zhao","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2021.113946_bib5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/17460441.2021.1877656","article-title":"An update on the emerging approaches for histone deacetylase (HDAC) inhibitor drug discovery and future perspectives","volume":"16","author":"Su","year":"2021","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113946_bib6","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/17460441.2021.1877656","article-title":"An update on the emerging approaches for histone deacetylase (HDAC) inhibitor drug discovery and future perspectives","volume":"16","author":"Su","year":"2021","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113946_bib7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13059-018-1533-y","article-title":"Dynamics and functional interplay of histone lysine butyrylation, crotonylation, and acetylation in rice under starvation and submergence","volume":"19","author":"Lu","year":"2018","journal-title":"Genome Biol."},{"key":"10.1016\/j.ejmech.2021.113946_bib8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.sbi.2018.10.001","article-title":"Beyond histone acetylation\u2014writing and erasing histone acylations","volume":"53","author":"Zhao","year":"2018","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ejmech.2021.113946_bib9","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/med.21437","article-title":"The search for potent, small-molecule HDACIs in cancer treatment: a decade after vorinostat","volume":"37","author":"Zagni","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2021.113946_bib10","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","article-title":"Histone deacetylases (HDACs): characterization of the classical HDAC family","volume":"370","author":"Ruijter","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2021.113946_bib11","doi-asserted-by":"crossref","first-page":"13708","DOI":"10.1073\/pnas.250477697","article-title":"Genomewide studies of histone deacetylase function in yeast","volume":"97","author":"Bernstein","year":"2000","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejmech.2021.113946_bib12","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1042\/BST20130010","article-title":"The physiological roles of histone deacetylase (HDAC) 1 and 2: complex co-stars with multiple leading parts","volume":"41","author":"Kelly","year":"2013","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejmech.2021.113946_bib13","doi-asserted-by":"crossref","first-page":"13716","DOI":"10.1074\/jbc.M609751200","article-title":"Enhanced deacetylation of p53 by the anti-apoptotic protein HSCO in association with histone deacetylase 1","volume":"282","author":"Higashitsuji","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib14","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/emboj\/19.4.662","article-title":"Regulation of E2F1 activity by acetylation","volume":"19","author":"Mart\u00ednez-Balb\u00e1s","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2021.113946_bib15","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.devcel.2010.08.012","article-title":"Hopx and Hdac2 interact to modulate Gata4 acetylation and embryonic cardiac myocyte proliferation","volume":"19","author":"Trivedi","year":"2010","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ejmech.2021.113946_bib16","first-page":"102","article-title":"Integrative regulation of physiology by histone deacetylase 3, Nature reviews","volume":"20","author":"Emmett","year":"2019","journal-title":"Molecular cell biology"},{"key":"10.1016\/j.ejmech.2021.113946_bib17","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1096\/fj.04-2303fje","article-title":"Histone deacetylase HDAC8 associates with smooth muscle alpha-actin and is essential for smooth muscle cell contractility","volume":"19","author":"Waltregny","year":"2005","journal-title":"Faseb. J. : official publication of the Federation of American Societies for Experimental Biology"},{"key":"10.1016\/j.ejmech.2021.113946_bib18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0002-9440(10)63320-2","article-title":"Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues","volume":"165","author":"Waltregny","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejmech.2021.113946_bib19","doi-asserted-by":"crossref","first-page":"9544","DOI":"10.1523\/JNEUROSCI.1826-05.2005","article-title":"Intracellular trafficking of histone deacetylase 4 regulates neuronal cell death","volume":"25","author":"Bolger","year":"2005","journal-title":"J.\u00a0Neurosci. : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.ejmech.2021.113946_bib20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1074-7613(03)00109-2","article-title":"HDAC7, a thymus-specific class II histone deacetylase, regulates Nur77 transcription and TCR-mediated apoptosis","volume":"18","author":"Dequiedt","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2021.113946_bib21","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1128\/MCB.24.19.8467-8476.2004","article-title":"Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development","volume":"24","author":"Chang","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2021.113946_bib22","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.molcel.2005.04.021","article-title":"HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor","volume":"18","author":"Kovacs","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2021.113946_bib23","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/emboj\/cdg115","article-title":"HDAC-6 interacts with and deacetylates tubulin and microtubules in\u00a0vivo","volume":"22","author":"Zhang","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2021.113946_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13045-018-0654-9","article-title":"Histone deacetylase 6 in cancer","volume":"11","author":"Li","year":"2018","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.ejmech.2021.113946_bib25","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1093\/nar\/25.18.3693","article-title":"Histone deacetylases, acetoin utilization proteins and acetylpolyamine amidohydrolases are members of an ancient protein superfamily","volume":"25","author":"Leipe","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2021.113946_bib26","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1074\/jbc.M108055200","article-title":"Isolation and characterization of a novel class II histone deacetylase, HDAC10","volume":"277","author":"Fischer","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib27","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1074\/jbc.M109861200","article-title":"Molecular cloning and characterization of a novel histone deacetylase HDAC10","volume":"277","author":"Guardiola","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/cells4020135","article-title":"HDAC family members intertwined in the regulation of autophagy: a druggable vulnerability in aggressive tumor entities","volume":"4","author":"Koeneke","year":"2015","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2021.113946_bib29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1074\/jbc.M108931200","article-title":"Isolation and characterization of mammalian HDAC10, a novel histone deacetylase","volume":"277","author":"Kao","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib30","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1074\/jbc.M109861200","article-title":"Molecular cloning and characterization of a novel histone deacetylase HDAC10","volume":"277","author":"Guardiola","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib31","doi-asserted-by":"crossref","first-page":"15368","DOI":"10.1038\/ncomms15368","article-title":"Histone deacetylase 10 structure and molecular function as a polyamine deacetylase","volume":"8","author":"Hai","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2021.113946_bib32","first-page":"54","article-title":"HDAC11 is a regulator of diverse immune functions, Biochimica et biophysica acta","volume":"1861","author":"Yanginlar","year":"2018","journal-title":"Gene regulatory mechanisms"},{"key":"10.1016\/j.ejmech.2021.113946_bib33","doi-asserted-by":"crossref","first-page":"12460","DOI":"10.1021\/acs.jmedchem.0c00830","article-title":"Thirty years of HDAC inhibitors: 2020 insight and hindsight","volume":"63","author":"Ho","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/1574892815666200217125419","article-title":"Novel selective histone deacetylase 6 (HDAC6) inhibitors: a patent review","volume":"15","author":"He","year":"2020","journal-title":"Recent Pat. Anti-Cancer Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113946_bib35","doi-asserted-by":"crossref","first-page":"114224","DOI":"10.1016\/j.bcp.2020.114224","article-title":"Dual inhibitors of histone deacetylases and other cancer-related targets: a pharmacological perspective","volume":"182","author":"Gao","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113946_bib36","doi-asserted-by":"crossref","first-page":"10246","DOI":"10.1021\/acs.jmedchem.0c00567","article-title":"Rational design of Suprastat: a novel selective histone deacetylase 6 inhibitor with the ability to potentiate immunotherapy in melanoma models","volume":"63","author":"Noonepalle","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib37","doi-asserted-by":"crossref","first-page":"112411","DOI":"10.1016\/j.ejmech.2020.112411","article-title":"PTG-0861: a novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia","volume":"201","author":"Gawel","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib38","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1021\/acs.jmedchem.0c01922","article-title":"Unique molecular interaction with the histone deacetylase 6 catalytic tunnel: crystallographic and biological characterization of a model chemotype","volume":"64","author":"Olaoye","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib39","doi-asserted-by":"crossref","first-page":"8486","DOI":"10.1021\/acs.jmedchem.1c00420","article-title":"Development of HDAC inhibitors exhibiting therapeutic potential in T-cell prolymphocytic leukemia","volume":"64","author":"Toutah","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib40","doi-asserted-by":"crossref","first-page":"127537","DOI":"10.1016\/j.bmcl.2020.127537","article-title":"Design, synthesis and evaluation of novel indirubin-based N-hydroxybenzamides, N-hydroxypropenamides and N-hydroxyheptanamides as histone deacetylase inhibitors and antitumor agents","volume":"30","author":"Anh","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113946_bib41","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1021\/acs.jmedchem.0c02210","article-title":"Tetrahydroquinoline-Capped histone deacetylase 6 inhibitor SW-101 ameliorates pathological phenotypes in a charcot\u2013marie\u2013tooth type 2A mouse model","volume":"64","author":"Shen","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib42","doi-asserted-by":"crossref","first-page":"113383","DOI":"10.1016\/j.ejmech.2021.113383","article-title":"Design, synthesis and biological evaluation of brain penetrant benzazepine-based histone deacetylase 6 inhibitors for alleviating stroke-induced brain infarction","volume":"218","author":"Guo","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib43","doi-asserted-by":"crossref","first-page":"10339","DOI":"10.1021\/acs.jmedchem.9b01888","article-title":"Multicomponent synthesis, binding mode, and structure\u2013activity relationship of selective histone deacetylase 6 (HDAC6) inhibitors with bifurcated capping groups","volume":"63","author":"Re\u00dfing","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib44","doi-asserted-by":"crossref","first-page":"111950","DOI":"10.1016\/j.ejmech.2019.111950","article-title":"Novel 2, 5-diketopiperazine derivatives as potent selective histone deacetylase 6 inhibitors: rational design, synthesis and antiproliferative activity","volume":"187","author":"Chen","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib45","doi-asserted-by":"crossref","first-page":"112998","DOI":"10.1016\/j.ejmech.2020.112998","article-title":"Novel quinolone-based potent and selective HDAC6 inhibitors: synthesis, molecular modeling studies and biological investigation","volume":"212","author":"Relitti","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib46","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1021\/acsmedchemlett.0c00395","article-title":"Spiroindoline-Capped selective HDAC6 inhibitors: design, synthesis, structural analysis, and biological evaluation","volume":"11","author":"Saraswati","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113946_bib47","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1021\/acs.jmedchem.0c01967","article-title":"HDAC7 inhibition by phenacetyl and phenylbenzoyl hydroxamates","volume":"64","author":"Mak","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib48","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1021\/ml400470s","article-title":"Potent and orally efficacious bisthiazole-based histone deacetylase inhibitors","volume":"5","author":"Chen","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113946_bib49","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1021\/acs.jmedchem.9b01792","article-title":"Synthesis and in\u00a0vitro and in\u00a0vivo biological evaluation of tissue-specific bisthiazole histone deacetylase (HDAC) inhibitors","volume":"63","author":"Zhang","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib50","doi-asserted-by":"crossref","first-page":"112193","DOI":"10.1016\/j.ejmech.2020.112193","article-title":"Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer's disease","volume":"192","author":"Tseng","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib51","doi-asserted-by":"crossref","first-page":"113419","DOI":"10.1016\/j.ejmech.2021.113419","article-title":"Synthesis and biological evaluation of phenothiazine derivative-containing hydroxamic acids as potent class II histone deacetylase inhibitors","volume":"219","author":"Hsu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib52","first-page":"117","article-title":"Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites","volume":"5","author":"Engel","year":"2015","journal-title":"Int. J. Parasitol.: Drugs and Drug Resistance"},{"key":"10.1016\/j.ejmech.2021.113946_bib53","doi-asserted-by":"crossref","first-page":"113065","DOI":"10.1016\/j.ejmech.2020.113065","article-title":"Investigation of the in\u00a0vitro and in\u00a0vivo efficacy of peptoid-based HDAC inhibitors with dual-stage antiplasmodial activity","volume":"211","author":"Mackwitz","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib54","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1021\/acs.jmedchem.0c00230","article-title":"Achiral derivatives of hydroxamate AR-42 potently inhibit class I HDAC enzymes and cancer cell proliferation","volume":"63","author":"Tng","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib55","doi-asserted-by":"crossref","first-page":"8634","DOI":"10.1021\/acs.jmedchem.0c01025","article-title":"Characterization of conformationally constrained benzanilide scaffolds for potent and selective HDAC8 targeting","volume":"63","author":"Hassan","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib56","doi-asserted-by":"crossref","first-page":"113392","DOI":"10.1016\/j.ejmech.2021.113392","article-title":"Identification of novel 1,3-diaryl-1,2,4-triazole-capped histone deacetylase 6 inhibitors with potential anti-gastric cancer activity","volume":"218","author":"Zhang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib57","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1021\/acsmedchemlett.9b00471","article-title":"Class I\/IIb-Selective HDAC inhibitor exhibits oral bioavailability and therapeutic efficacy in acute myeloid leukemia","volume":"11","author":"Shouksmith","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113946_bib58","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1021\/acs.jmedchem.0c02104","article-title":"Discovery of novel plasmodium falciparum HDAC1 inhibitors with dual-stage antimalarial potency and improved safety based on the clinical anticancer drug candidate quisinostat","volume":"64","author":"Li","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib59","doi-asserted-by":"crossref","first-page":"103988","DOI":"10.1016\/j.bioorg.2020.103988","article-title":"Exploration of certain 1,3-oxazole- and 1,3-thiazole-based hydroxamic acids as histone deacetylase inhibitors and antitumor agents","volume":"101","author":"Anh","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib60","doi-asserted-by":"crossref","first-page":"111915","DOI":"10.1016\/j.ejmech.2019.111915","article-title":"Protective effects of 10,11-dihydro-5H-dibenzo[b,f]azepine hydroxamates on vascular cognitive impairment","volume":"187","author":"Kaur","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib61","doi-asserted-by":"crossref","first-page":"104023","DOI":"10.1016\/j.bioorg.2020.104023","article-title":"Design, synthesis and biological evaluation of coumarin-based N-hydroxycinnamamide derivatives as novel histone deacetylase inhibitors with anticancer activities","volume":"101","author":"Ding","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib62","doi-asserted-by":"crossref","first-page":"116085","DOI":"10.1016\/j.bmc.2021.116085","article-title":"Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors","volume":"35","author":"Tavares","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib63","doi-asserted-by":"crossref","first-page":"115345","DOI":"10.1016\/j.bmc.2020.115345","article-title":"Pyrimethamine conjugated histone deacetylase inhibitors: design, synthesis and evidence for triple negative breast cancer selective cytotoxicity","volume":"28","author":"Wu","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib64","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1021\/acs.jmedchem.0c00442","article-title":"Design of hydrazide-bearing HDACIs based on panobinostat and their p53 and FLT3-ITD dependency in antileukemia activity","volume":"63","author":"Li","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib65","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1021\/acs.jmedchem.0c01763","article-title":"Novel carboline fungal histone deacetylase (HDAC) inhibitors for combinational treatment of azole-resistant candidiasis","volume":"64","author":"Li","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib66","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1021\/acsmedchemlett.0c00369","article-title":"Studying histone deacetylase inhibition and apoptosis induction of psammaplin A monomers with modified thiol group","volume":"12","author":"Bao","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113946_bib67","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1021\/ci500493m","article-title":"Structure and ligand-based design of mTOR and PI3-kinase inhibitors leading to the clinical candidates VS-5584 (SB2343) and SB2602","volume":"54","author":"Poulsen","year":"2014","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2021.113946_bib68","doi-asserted-by":"crossref","first-page":"103724","DOI":"10.1016\/j.bioorg.2020.103724","article-title":"Synthesis and biological evaluation of 6-phenylpurine linked hydroxamates as novel histone deacetylase inhibitors","volume":"98","author":"Chen","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib69","doi-asserted-by":"crossref","first-page":"112189","DOI":"10.1016\/j.ejmech.2020.112189","article-title":"Design, synthesis and biological evaluation of novel indazole-based derivatives as potent HDAC inhibitors via fragment-based virtual screening","volume":"192","author":"Liu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib70","doi-asserted-by":"crossref","first-page":"112648","DOI":"10.1016\/j.ejmech.2020.112648","article-title":"Design, synthesis and biological evaluation of novel HDAC inhibitors with improved pharmacokinetic profile in breast cancer","volume":"205","author":"Yao","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib71","doi-asserted-by":"crossref","first-page":"112677","DOI":"10.1016\/j.ejmech.2020.112677","article-title":"Design and synthesis of novel Flavone-based histone deacetylase inhibitors antagonizing activation of STAT3 in breast cancer","volume":"206","author":"Wei","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib72","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41591-019-0376-8","article-title":"Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer","volume":"25","author":"Mohammad","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2021.113946_bib73","doi-asserted-by":"crossref","first-page":"113095","DOI":"10.1016\/j.ejmech.2020.113095","article-title":"Synergistic induction of apoptosis in resistant head and neck carcinoma and leukemia by alkoxyamide-based histone deacetylase inhibitors","volume":"211","author":"Alves Avelar","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib74","doi-asserted-by":"crossref","first-page":"113338","DOI":"10.1016\/j.ejmech.2021.113338","article-title":"Pragmatic recruitment of memantine as the capping group for the design of HDAC inhibitors: a preliminary attempt to unravel the enigma of glioblastoma","volume":"217","author":"Nepali","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib75","doi-asserted-by":"crossref","first-page":"104652","DOI":"10.1016\/j.bioorg.2021.104652","article-title":"Design, synthesis and antitumor activity evaluation of novel HDAC inhibitors with tetrahydrobenzothiazole as the skeleton","volume":"108","author":"Sun","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib76","doi-asserted-by":"crossref","first-page":"115108","DOI":"10.1016\/j.bmc.2019.115108","article-title":"Novel alkoxyamide-based histone deacetylase inhibitors reverse cisplatin resistance in chemoresistant cancer cells","volume":"28","author":"Asfaha","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib77","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2147\/OTT.S93528","article-title":"Chidamide in the treatment of peripheral T-cell lymphoma","volume":"10","author":"Chan","year":"2017","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ejmech.2021.113946_bib78","doi-asserted-by":"crossref","first-page":"112291","DOI":"10.1016\/j.ejmech.2020.112291","article-title":"Purine\/purine isoster based scaffolds as new derivatives of benzamide class of HDAC inhibitors","volume":"196","author":"Nepali","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib79","doi-asserted-by":"crossref","first-page":"105050","DOI":"10.1016\/j.bioorg.2021.105050","article-title":"Synthesis, biological evaluation, and molecular docking analysis of novel linker-less benzamide based potent and selective HDAC3 inhibitors","volume":"114","author":"Routholla","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib80","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cmdc.201500486","article-title":"Why hydroxamates may not Be the best histone deacetylase inhibitors--what some may have forgotten or would rather forget?","volume":"11","author":"Shen","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113946_bib81","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1039\/C5OB00301F","article-title":"Investigations of possible prodrug structures for 2-(2-mercaptophenyl)tetrahydropyrimidines: reductive conversion from anti-HIV agents with pyrimidobenzothiazine and isothiazolopyrimidine scaffolds","volume":"13","author":"Okazaki","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib82","doi-asserted-by":"crossref","first-page":"111756","DOI":"10.1016\/j.ejmech.2019.111756","article-title":"Synthesis and structure activity relationship of 1, 3-benzo-thiazine-2-thiones as selective HDAC8 inhibitors","volume":"184","author":"Wolff","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib83","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1021\/acsmedchemlett.0c00532","article-title":"Evaluation of 5-(Trifluoromethyl)-1,2,4-oxadiazole-Based class IIa HDAC inhibitors for Huntington's disease","volume":"12","author":"Stott","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113946_bib84","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1021\/acsmedchemlett.0c00462","article-title":"Discovery of highly selective and potent HDAC3 inhibitors based on a 2-substituted benzamide zinc binding group","volume":"11","author":"Liu","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113946_bib85","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1021\/acsmedchemlett.1c00074","article-title":"Redefining the histone deacetylase inhibitor pharmacophore: high potency with No zinc cofactor interaction","volume":"12","author":"Beshore","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113946_bib86","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1021\/acs.jmedchem.0c02150","article-title":"Discovery of ethyl ketone-based highly selective HDACs 1, 2, 3 inhibitors for HIV latency reactivation with minimum cellular potency serum shift and reduced hERG activity","volume":"64","author":"Yu","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib87","doi-asserted-by":"crossref","first-page":"127367","DOI":"10.1016\/j.bmcl.2020.127367","article-title":"Development of a selective HDAC inhibitor aimed at reactivating the HIV latent reservoir","volume":"30","author":"Clausen","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113946_bib88","doi-asserted-by":"crossref","first-page":"128168","DOI":"10.1016\/j.bmcl.2021.128168","article-title":"Discovery of macrocyclic HDACs 1, 2, and 3 selective inhibitors for HIV latency reactivation","volume":"47","author":"Yu","year":"2021","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113946_bib89","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1021\/acsmedchemlett.0c00596","article-title":"Synthesis of HDAC inhibitor libraries via microscale workflow","volume":"12","author":"Dykstra","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113946_bib90","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1021\/acsmedchemlett.0c00302","article-title":"Selective class I HDAC inhibitors based on aryl ketone zinc binding induce HIV-1 protein for clearance","volume":"11","author":"Liu","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113946_bib91","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ddtec.2019.01.002","article-title":"PROteolysis TArgeting Chimeras (PROTACs) - past, present and future","volume":"31","author":"Pettersson","year":"2019","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ejmech.2021.113946_bib92","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1039\/D0CC01485K","article-title":"PROTAC-mediated degradation of class I histone deacetylase enzymes in corepressor complexes","volume":"56","author":"Smalley","year":"2020","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2021.113946_bib93","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bcp.2016.03.010","article-title":"HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-\u03baB p65 transcriptional activity","volume":"108","author":"Leus","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113946_bib94","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.chembiol.2014.12.015","article-title":"Identification of histone deacetylase inhibitors with benzoylhydrazide scaffold that selectively inhibit class I histone deacetylases","volume":"22","author":"Wang","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113946_bib95","doi-asserted-by":"crossref","first-page":"9866","DOI":"10.1039\/D0CC03243C","article-title":"Discovery of histone deacetylase 3 (HDAC3)-specific PROTACs","volume":"56","author":"Xiao","year":"2020","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2021.113946_bib96","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1021\/acs.jmedchem.9b00516","article-title":"Development of multifunctional histone deacetylase 6 degraders with potent antimyeloma activity","volume":"62","author":"Wu","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib97","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature13527","article-title":"Structure of the DDB1\u2013CRBN E3 ubiquitin ligase in complex with thalidomide","volume":"512","author":"Fischer","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113946_bib98","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1021\/acsmedchemlett.0c00046","article-title":"Development of selective histone deacetylase 6 (HDAC6) degraders recruiting von hippel-lindau (VHL) E3 ubiquitin ligase","volume":"11","author":"Yang","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113946_bib99","doi-asserted-by":"crossref","first-page":"22494","DOI":"10.1002\/anie.202006725","article-title":"Hydroxamic acids immobilized on resins (HAIRs): synthesis of dual-targeting HDAC inhibitors and HDAC degraders (PROTACs)","volume":"59","author":"Sinatra","year":"2020","journal-title":"Angew. Chem."},{"key":"10.1016\/j.ejmech.2021.113946_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2021.07.002","article-title":"Chemo-proteomics exploration of HDAC degradability by small molecule degraders","author":"Xiong","year":"2021","journal-title":"Cell Chem Biol"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421007959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421007959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:42:50Z","timestamp":1759329770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421007959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":100,"alternative-id":["S0223523421007959"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113946","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medicinal chemistry updates of novel HDACs inhibitors (2020 to present)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113946","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113946"}}